Harikrishna K. R. Nair MD, OSH, OHD, CMIA, CHM, ESWT, FMSWCP, PG

Dr. Harikrishna KR Nair, head consultant of the Wound Care Unit, Department of Internal Medicine, at the Kuala Lumpur Hospital in Malaysia has initiated a 30-patient clinical trial.

The goal of the clinical trial is to evaluate the effectiveness of NATROX® Oxygen Wound Therapy on non-healing diabetic foot ulcers. The key endpoints of the study are the number of participants that achieve complete wound closure during the 12-week study and the percentage reduction in wound size after 12 weeks.

The study is already underway with 2 patients enrolled.

Dr. Harikrishna KR Nair commented that “after seeing promising results achieved with NATROX® O₂ in my clinical practice, it seemed sensible to formally evaluate the potential impact that NATROX® O₂ could have on patients affected by diabetic foot ulcers.”

It is estimated that 422 million (8.5%) of the world’s adult population has diabetes. Malaysia has an even greater prevalence; in 2014, it was estimated that 2.6 million Malaysians had diabetes, which equates to over 15% of the total population and we know that people with diabetes have a one-in-four risk of developing a diabetic foot ulcer (DFU) in their lifetime.

The study will be held at the HKL Hospital in Kuala Lumpur in Malaysia and the enrolment phase is expected to run for 4 months.